echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The limit is approaching 44 large varieties from August 1st to transfer a local health insurance

    The limit is approaching 44 large varieties from August 1st to transfer a local health insurance

    • Last Update: 2021-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical network February 20th, the big limit approaching, local medical insurance transfer work continues, 44 large varieties from August 1st transferred out of a local medical insurance catalog 44 large varieties transferred out of health insurance according to the Sichuan Medical Insurance Bureau issued about the transfer of some drugs out of Sichuan Province basic medical insurance, work injury insurance and The notice of the Maternity Insurance Drug Catalog (2018 edition) states that 44 drugs, such as aluminum magnesium pills (II), will be transferred out of the Drug Catalog on August 1, 2021, and the above-mentioned drugs shall continue to be paid in accordance with the relevant provisions of the Drug Catalog until they are transferred.
    According to Cypress Blue Combs, the drugs that will be transferred out of health insurance from August 1, 2021 are: cephalosporine for injectionshubatan, injection with inflamed amberin, potassium meningitone injections, heart-wearing lotus pills, and sodium chloride injections for quick reed.
    Sichuan Health Insurance Bureau pointed out in the relevant interpretation, aluminum magnesium pills (II) and other 44 kinds of drugs are in accordance with the relevant provisions of the reimbursement transition period of drugs.
    At present, insured personnel and some medical institutions are still in use, in order to ensure the continuity of drug use of insured personnel, support pharmaceutical enterprises to resume work and epidemic prevention and control, to give a certain buffer time, so the provisions from August 1, 2021.
    previously, according to the MiNet database, 37 of the more than 1 billion products in China's public medical institutions in 2019 were local health insurance catalogue varieties, with total sales of 76.9 billion yuan.
    , that is, the clean-up of local health care will affect at least 70 billion drug markets.
    source: Minet China's public medical institutions terminal competition pattern according to the above-mentioned notice, earlier, there have been 100 drugs transferred out of Sichuan Province's health insurance directory - into the scope of national key monitoring of the conversion of sugar electrolyte injections and other 6 drugs from July 1, 2020;
    The analysis points out that the transfer of drugs from local medical insurance is an important measure to implement the Opinions of the State Council of the CPC Central Committee on Deepening the Reform of the Medical Security System, which is of great significance for regulating the adjustment of the rights and responsibilities of the drug catalogue and gradually realizing the unification of the scope of medical insurance use throughout the country.
    , article 12 of the Opinions of the State Council of the CPC Central Committee on Deepening the Reform of the Medical Security System clearly stipulates that the dynamic adjustment mechanism of the medical insurance catalogue should be improved.
    Based on the fund's affordability, adapt to the basic medical needs of the masses, clinical technological progress, adjust and optimize the list of medical insurance, the clinical value of high, excellent economic evaluation of drugs, medical treatment projects, medical supplies into the scope of medical insurance payment, regulate the scope of payment of medical services facilities.
    the dynamic adjustment mechanism of the medical insurance catalogue and improve the system of medical insurance access negotiation.
    to reasonably divide the central and local catalogues to adjust their duties and authority, all regions shall not make their own catalogues or adjust the scope of limited payment for medical insurance drugs, and gradually realize the basic unification of the scope of medical insurance use throughout the country.
    establish a system of evaluation rules and indicators for medical insurance drugs, medical treatment projects and medical supplies, and improve the exit mechanism.
    The end of June 2022 is an earlier deadline, and on August 20, 2019, the State Health Insurance Administration issued the Notice of the Ministry of Human Resources and Social Security of the State Administration of Health Insurance on the Publication of the National List of Essential Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs.
    class B drugs added in the original provincial drug catalogue should be gradually digested within 3 years.
    the digestion process, provinces should give priority to adjusting the scope of payments for medicines that are included in the scope of national key monitoring.
    The arrangements for the transfer of local additional varieties out of medical insurance are as follows: 1, the key monitoring catalogue drugs take the lead in moving out of the medical insurance catalogue;
    , July 1, 2020, September 1, 2020, October 1, 2020, and January 1, 2021 are the main time limits for some local health insurance varieties to stop reimbursement, according to Seber Blue.
    to the provinces and local supplements to withdraw from health insurance restrictions mainly concentrated in late June 2022.
    Health insurance cage change birds continue to follow, December 28, 2020, the 2020 edition of the medical insurance directory officially announced, the State Health Insurance Administration in the same day's notice at the same time clearly, the provincial health insurance departments to speed up the original self-replenishing varieties of digestion work, according to the requirements to clean up the "interim measures for the management of basic medical insurance drugs" requirements of the varieties, to promote the basic unification of the scope of drug use.
    In accordance with the Interim Measures for the Administration of Essential Medical Insurance Drugs, which came into effect on September 1, 2020, the drug in the Drug Catalog shall be withdrawn, revoked or cancelled by the drug regulatory department after expert review, and the Drug Catalog :(1) shall be directly called out after expert review. drugs; (2) drugs listed negatively by the relevant departments; (3) drugs assessed as more risky than beneficial, taking into account such factors as clinical value, adverse reactions and drug economy; (4) drugs entering the Drug Catalog by means of fraud and other irregularities; and (5) other circumstances that should be directly transferred under the State.
    If the drugs in the Drug Catalog meet one of the following conditions, after expert review and other prescribed procedures, the Drug Catalog :(1) may be transferred out of the same treatment field, the price or cost is significantly higher and there is no reasonable reason for the drug;
    it is not difficult to see that health insurance in the increase of payment for innovative drugs at the same time, but also through the volume of procurement, medical insurance catalog to speed up adjustment, local health insurance clean-up and other means to achieve the health insurance fund cage for birds.
    no. drug name and dosage form dialed out of the catalog time 1 aluminum magnesium pills (II) August 1, 2021 2 alenin sodium vitamin D3 tablets August 1, 2021 3 latandine drops eye drops August 1, 2021 4 injections with ampicillin sodium chloroxilin 2021 August 1, 2021 5 injections with 12 Multivitamin August 1, 2021 6potassium acid titnitricin / kramycin tablet combination package August 1, 2021 7 compound sodium aweitate aspirin capsule August 1, 2021 8 low molecule right glycosterone amino acid injection August 1, 2021 9 injected lipid-soluble vitamin (II)/ Injection with water-soluble vitamin combination packaging August 1, 2021 10 injections with cephalosporine Shubatan August 1, 2021 11 erythromycin ammonia bromosomal dispersion tablets August 1, 2021 12 compound amino acids (15) double peptide (2) injection August 1, 2021 13 injection compound three-dimensional B (II) August 1, 2021 14 sodium chloride injection of parasulphate Pajusha star August 1, 2021 15 hydrochloride Ondans Joan chloride injection August 1, 2021 16 hydrochloric acid toast joan chloride injection August 1, 2021 17 acetyl glutamine sodium chloride injection August 1, 2021 18 Dosso-tea-alkali glucose injection August 1, 2021 19 Ozagra sodium chloride injection August 1, 2021 20th sulphate itimi star sodium chloride injection August 1, 2021 21 piracetamate sodium chloride injection August 1, 2021 22 stamin bromide glucose injection August 2021 1st 23rd sodium creatine chloride injection August 1st, 2021 24 glycosin glucose injection August 1st, 2021 25 plus satin glucose injection August 1st, 2021 26 trophic sodium reed chloride injection August 1, 2021 27th sodium chloride injection 20218 28 Sodium chloride injection on August 1, 2021 29 potassium chloride glucose injection August 1, 2021 30 vitamin C glucose injection August 1, 2021 31 vitamin C sodium chloride injection August 1, 2021 32 Compound right-hand glycosin 40 injection August 1, 2021 33 injection with sodium felate August 1, 2021 34 compound vitamin injection (4) August 1, 2021 35 polysaccharide iron capsule August 1, 2021 36 calf spleen extraction Injection August 1, 2021 37-door potassium hysterine injection August 1, 2021 38 injections with dibutaminated cyclophosphate calcium August 1, 2021 39-door hololine birdine particles August 1, 2021 40 through the heart lotus ticks 20 August 1, 21 21 41 compound calcium carbonate particles August 1, 2021 42 injection of yan amberin August 1, 2021 4318 amino acid injections August 1, 2021 44 thin sesame peptide injection August 1, 2021
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.